Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 30 | 2024 | 2669 | 3.860 |
Why?
|
Geriatric Assessment | 20 | 2024 | 1422 | 2.230 |
Why?
|
Frail Elderly | 17 | 2024 | 781 | 1.710 |
Why?
|
Peptidylprolyl Isomerase | 4 | 2015 | 97 | 1.350 |
Why?
|
Hematologic Neoplasms | 10 | 2023 | 1907 | 1.160 |
Why?
|
Patient Care Management | 2 | 2021 | 303 | 1.110 |
Why?
|
Alzheimer Disease | 14 | 2019 | 8759 | 0.970 |
Why?
|
Neoplasms | 23 | 2023 | 22371 | 0.940 |
Why?
|
Pharmacists | 3 | 2021 | 261 | 0.870 |
Why?
|
Aftercare | 3 | 2023 | 916 | 0.750 |
Why?
|
Geriatrics | 3 | 2022 | 394 | 0.740 |
Why?
|
Aged | 80 | 2024 | 171502 | 0.680 |
Why?
|
Neurodegenerative Diseases | 3 | 2022 | 1094 | 0.660 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3251 | 0.640 |
Why?
|
Multiple Myeloma | 5 | 2024 | 5196 | 0.630 |
Why?
|
Parkinson Disease | 7 | 2014 | 2893 | 0.630 |
Why?
|
Aged, 80 and over | 42 | 2024 | 59626 | 0.600 |
Why?
|
Rehabilitation | 1 | 2019 | 129 | 0.590 |
Why?
|
Aging | 8 | 2023 | 8743 | 0.560 |
Why?
|
United States Department of Veterans Affairs | 7 | 2024 | 937 | 0.530 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.530 |
Why?
|
Hand Strength | 1 | 2019 | 466 | 0.520 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 220 | 0.510 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15662 | 0.500 |
Why?
|
Pharmaceutical Services | 1 | 2016 | 143 | 0.480 |
Why?
|
Dementia | 4 | 2024 | 2740 | 0.480 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 228 | 0.470 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 329 | 0.450 |
Why?
|
Gait | 1 | 2019 | 823 | 0.440 |
Why?
|
Humans | 113 | 2024 | 768171 | 0.420 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.420 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2022 | 2271 | 0.420 |
Why?
|
Proportional Hazards Models | 11 | 2020 | 12543 | 0.420 |
Why?
|
Physicians | 4 | 2022 | 4598 | 0.400 |
Why?
|
Patient Discharge | 5 | 2023 | 3479 | 0.400 |
Why?
|
Clinical Coding | 1 | 2012 | 188 | 0.350 |
Why?
|
Parkinson Disease, Secondary | 1 | 2011 | 120 | 0.350 |
Why?
|
Stroke | 3 | 2023 | 9755 | 0.350 |
Why?
|
Comorbidity | 9 | 2023 | 10590 | 0.350 |
Why?
|
Selection, Genetic | 1 | 2015 | 877 | 0.340 |
Why?
|
Sexual Harassment | 2 | 2021 | 82 | 0.340 |
Why?
|
Patients | 1 | 2016 | 908 | 0.340 |
Why?
|
Metformin | 1 | 2017 | 909 | 0.330 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1498 | 0.330 |
Why?
|
Male | 59 | 2024 | 364731 | 0.330 |
Why?
|
Age Factors | 9 | 2019 | 18415 | 0.330 |
Why?
|
Cardiology | 1 | 2021 | 1702 | 0.330 |
Why?
|
Aspirin | 4 | 2021 | 3135 | 0.310 |
Why?
|
Cohort Studies | 18 | 2023 | 41753 | 0.310 |
Why?
|
Smoking | 6 | 2012 | 9092 | 0.310 |
Why?
|
Risk Factors | 22 | 2024 | 74944 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2846 | 0.300 |
Why?
|
United States | 25 | 2024 | 73039 | 0.300 |
Why?
|
Endometrial Neoplasms | 1 | 2017 | 1382 | 0.290 |
Why?
|
Hospitals, Veterans | 5 | 2024 | 395 | 0.290 |
Why?
|
Quality Improvement | 6 | 2024 | 3857 | 0.290 |
Why?
|
Prospective Studies | 18 | 2024 | 54924 | 0.280 |
Why?
|
Energy Metabolism | 2 | 2019 | 2907 | 0.270 |
Why?
|
Quality of Life | 3 | 2021 | 13490 | 0.270 |
Why?
|
Models, Neurological | 1 | 2015 | 1776 | 0.270 |
Why?
|
Sickness Impact Profile | 1 | 2007 | 299 | 0.250 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1399 | 0.240 |
Why?
|
Female | 43 | 2024 | 397187 | 0.240 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3109 | 0.240 |
Why?
|
Kaplan-Meier Estimate | 4 | 2019 | 6525 | 0.230 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3252 | 0.230 |
Why?
|
Marital Status | 3 | 2023 | 426 | 0.220 |
Why?
|
Neurons | 4 | 2018 | 9514 | 0.220 |
Why?
|
Confidence Intervals | 3 | 2017 | 2923 | 0.220 |
Why?
|
Telemedicine | 2 | 2022 | 3109 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3626 | 0.210 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3604 | 0.200 |
Why?
|
Risk Adjustment | 2 | 2021 | 599 | 0.200 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15949 | 0.200 |
Why?
|
Health Status | 2 | 2017 | 4091 | 0.190 |
Why?
|
Nurse's Role | 1 | 2023 | 188 | 0.190 |
Why?
|
Retrospective Studies | 14 | 2023 | 81760 | 0.190 |
Why?
|
Nerve Degeneration | 2 | 2018 | 749 | 0.190 |
Why?
|
Myocardial Infarction | 3 | 2022 | 11519 | 0.190 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12795 | 0.190 |
Why?
|
Neuropsychology | 1 | 2022 | 110 | 0.180 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11244 | 0.180 |
Why?
|
tau Proteins | 3 | 2017 | 2144 | 0.180 |
Why?
|
Helping Behavior | 1 | 2020 | 21 | 0.180 |
Why?
|
Social Participation | 1 | 2022 | 187 | 0.180 |
Why?
|
Patient Identification Systems | 1 | 2020 | 75 | 0.170 |
Why?
|
Mitochondria | 1 | 2013 | 3683 | 0.170 |
Why?
|
Middle Aged | 27 | 2024 | 223487 | 0.170 |
Why?
|
Skilled Nursing Facilities | 1 | 2024 | 405 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2017 | 12252 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 16044 | 0.170 |
Why?
|
Amyloid | 2 | 2015 | 853 | 0.170 |
Why?
|
Hospitalization | 5 | 2023 | 10840 | 0.160 |
Why?
|
Population Dynamics | 1 | 2021 | 314 | 0.160 |
Why?
|
Anorexia Nervosa | 2 | 2019 | 1364 | 0.160 |
Why?
|
Medication Reconciliation | 1 | 2021 | 153 | 0.160 |
Why?
|
Long-Term Care | 1 | 2023 | 631 | 0.160 |
Why?
|
Workflow | 2 | 2021 | 860 | 0.160 |
Why?
|
Self Report | 2 | 2024 | 3773 | 0.160 |
Why?
|
Prognosis | 9 | 2023 | 30009 | 0.160 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5863 | 0.150 |
Why?
|
Knowledge Bases | 1 | 2019 | 97 | 0.150 |
Why?
|
Survival Analysis | 4 | 2018 | 10099 | 0.150 |
Why?
|
Electronic Health Records | 5 | 2024 | 4887 | 0.150 |
Why?
|
Accidental Falls | 2 | 2024 | 1080 | 0.150 |
Why?
|
Age Distribution | 3 | 2009 | 2873 | 0.150 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 939 | 0.150 |
Why?
|
Incidence | 8 | 2017 | 21538 | 0.150 |
Why?
|
Acetaminophen | 1 | 2022 | 552 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2023 | 905 | 0.150 |
Why?
|
beta Carotene | 2 | 2010 | 523 | 0.150 |
Why?
|
Patient Participation | 1 | 2007 | 1447 | 0.150 |
Why?
|
Mass Screening | 2 | 2016 | 5458 | 0.140 |
Why?
|
Maine | 1 | 2016 | 146 | 0.130 |
Why?
|
Heart Failure | 2 | 2019 | 11879 | 0.130 |
Why?
|
Dexamethasone | 1 | 2023 | 1965 | 0.130 |
Why?
|
Quantitative Trait, Heritable | 1 | 2019 | 540 | 0.130 |
Why?
|
Signal Transduction | 2 | 2018 | 23648 | 0.120 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39354 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2021 | 937 | 0.120 |
Why?
|
Program Evaluation | 3 | 2021 | 2507 | 0.120 |
Why?
|
Chronic Disease | 1 | 2010 | 9384 | 0.120 |
Why?
|
Review Literature as Topic | 1 | 2017 | 297 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.120 |
Why?
|
Epidemiologic Factors | 1 | 2014 | 36 | 0.120 |
Why?
|
Risk Assessment | 7 | 2024 | 24318 | 0.120 |
Why?
|
Brain Injuries | 2 | 2017 | 2057 | 0.120 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2023 | 4640 | 0.120 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2022 | 3729 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1106 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2022 | 22290 | 0.110 |
Why?
|
Occupational Health | 1 | 2020 | 812 | 0.110 |
Why?
|
Patient Selection | 2 | 2021 | 4260 | 0.110 |
Why?
|
Life Style | 3 | 2018 | 3932 | 0.110 |
Why?
|
Professional Role | 1 | 2016 | 316 | 0.110 |
Why?
|
Stochastic Processes | 1 | 2015 | 360 | 0.110 |
Why?
|
Thermodynamics | 1 | 2015 | 591 | 0.110 |
Why?
|
New England | 2 | 2015 | 1058 | 0.100 |
Why?
|
SEER Program | 1 | 2018 | 1444 | 0.100 |
Why?
|
Outpatients | 1 | 2021 | 1600 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2018 | 772 | 0.100 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 748 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2020 | 1835 | 0.100 |
Why?
|
Central Nervous System Diseases | 1 | 2017 | 520 | 0.100 |
Why?
|
Adult | 17 | 2023 | 223646 | 0.100 |
Why?
|
Proline | 1 | 2014 | 455 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.100 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 417 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2022 | 5315 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1542 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 957 | 0.090 |
Why?
|
Tauopathies | 1 | 2015 | 328 | 0.090 |
Why?
|
Cognition | 2 | 2021 | 7073 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1567 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 12840 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1541 | 0.090 |
Why?
|
Cause of Death | 2 | 2020 | 3721 | 0.090 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5891 | 0.090 |
Why?
|
Disabled Persons | 1 | 2020 | 1210 | 0.090 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2430 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10397 | 0.090 |
Why?
|
Odds Ratio | 3 | 2017 | 9669 | 0.080 |
Why?
|
Life Expectancy | 1 | 2016 | 1248 | 0.080 |
Why?
|
Animals | 8 | 2018 | 169285 | 0.080 |
Why?
|
Primary Health Care | 2 | 2023 | 4746 | 0.080 |
Why?
|
Patient Readmission | 2 | 2024 | 3288 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2014 | 1117 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2535 | 0.080 |
Why?
|
Meta-Analysis as Topic | 3 | 2017 | 1363 | 0.070 |
Why?
|
Hospitals | 1 | 2021 | 3886 | 0.070 |
Why?
|
Neuropsychological Tests | 4 | 2023 | 7140 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6975 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3384 | 0.070 |
Why?
|
Algorithms | 2 | 2024 | 14164 | 0.070 |
Why?
|
Family | 1 | 2017 | 3209 | 0.070 |
Why?
|
Software | 1 | 2020 | 4480 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15453 | 0.070 |
Why?
|
Protein Conformation | 1 | 2014 | 3956 | 0.060 |
Why?
|
Rural Population | 1 | 2016 | 2325 | 0.060 |
Why?
|
Prevalence | 4 | 2019 | 15869 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1119 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3231 | 0.060 |
Why?
|
Referral and Consultation | 3 | 2022 | 3620 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18065 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2018 | 3980 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3433 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
Models, Animal | 1 | 2010 | 2122 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2008 | 12077 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13677 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4310 | 0.060 |
Why?
|
Delirium | 1 | 2015 | 1696 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2009 | 969 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14783 | 0.050 |
Why?
|
Mortality | 2 | 2020 | 2911 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5432 | 0.050 |
Why?
|
Institutionalization | 1 | 2023 | 108 | 0.050 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 806 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 5919 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11878 | 0.050 |
Why?
|
England | 1 | 2024 | 533 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2934 | 0.050 |
Why?
|
State Medicine | 1 | 2024 | 219 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4861 | 0.050 |
Why?
|
Coronary Artery Bypass | 2 | 2023 | 2191 | 0.050 |
Why?
|
Behavioral Symptoms | 1 | 2024 | 188 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10478 | 0.050 |
Why?
|
Retirement | 1 | 2023 | 198 | 0.050 |
Why?
|
Genome, Human | 1 | 2015 | 4446 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8648 | 0.050 |
Why?
|
Databases, Factual | 1 | 2017 | 8080 | 0.050 |
Why?
|
Health Behavior | 2 | 2011 | 2650 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18349 | 0.050 |
Why?
|
Technology | 1 | 2023 | 296 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 65379 | 0.040 |
Why?
|
Phenotype | 2 | 2019 | 16726 | 0.040 |
Why?
|
Risk | 3 | 2019 | 9613 | 0.040 |
Why?
|
Polypharmacy | 1 | 2022 | 307 | 0.040 |
Why?
|
Policy | 1 | 2023 | 513 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26379 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 630 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2709 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11930 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
Systems Integration | 1 | 2020 | 430 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5520 | 0.040 |
Why?
|
Veterans Health | 1 | 2020 | 216 | 0.040 |
Why?
|
Axons | 2 | 2017 | 1677 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6229 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9262 | 0.040 |
Why?
|
Attitude to Health | 1 | 2007 | 2025 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10632 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8616 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9374 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13586 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 60066 | 0.030 |
Why?
|
Walking | 1 | 2023 | 1201 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 584 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2015 | 252 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2019 | 1328 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 800 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.030 |
Why?
|
Adolescent | 3 | 2017 | 89169 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2278 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2019 | 1997 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5367 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1755 | 0.030 |
Why?
|
Brain | 2 | 2017 | 27362 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1610 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1724 | 0.030 |
Why?
|
Recovery of Function | 1 | 2023 | 2981 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1969 | 0.030 |
Why?
|
Memory Disorders | 1 | 2019 | 1200 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3490 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14729 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2018 | 1007 | 0.020 |
Why?
|
Research Design | 2 | 2017 | 6209 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2346 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1761 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2302 | 0.020 |
Why?
|
Patient Care Team | 1 | 2022 | 2523 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2131 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 13053 | 0.020 |
Why?
|
Hong Kong | 1 | 2010 | 170 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2010 | 294 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2010 | 315 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3953 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 866 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5884 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2527 | 0.020 |
Why?
|
Drug Discovery | 1 | 2016 | 1068 | 0.020 |
Why?
|
Attention | 1 | 2019 | 2423 | 0.020 |
Why?
|
Melanoma | 1 | 2007 | 5706 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4818 | 0.020 |
Why?
|
Mice | 2 | 2015 | 82049 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1408 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 2009 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 858 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2711 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8741 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 806 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8316 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6029 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2451 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8890 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12466 | 0.020 |
Why?
|
Insulin | 1 | 2019 | 6610 | 0.010 |
Why?
|
Blood Glucose | 1 | 2019 | 6431 | 0.010 |
Why?
|
Palliative Care | 1 | 2019 | 3643 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3436 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6809 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3837 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5756 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13290 | 0.010 |
Why?
|
Women's Health | 1 | 2011 | 2082 | 0.010 |
Why?
|
Child | 2 | 2022 | 80917 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10873 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3428 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 17142 | 0.010 |
Why?
|
Body Weight | 1 | 2011 | 4627 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6340 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8747 | 0.010 |
Why?
|
Smoking Cessation | 1 | 2011 | 2085 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40220 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22380 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5797 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2011 | 4045 | 0.010 |
Why?
|
Computational Biology | 1 | 2010 | 3567 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 13045 | 0.010 |
Why?
|
Exercise | 1 | 2011 | 5954 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8089 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9617 | 0.010 |
Why?
|
Transcription Factors | 1 | 2010 | 12171 | 0.010 |
Why?
|